Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1994-7-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0077-8923
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
18
|
pubmed:volume |
714
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-52
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:8017791-Animals,
pubmed-meshheading:8017791-Disease Models, Animal,
pubmed-meshheading:8017791-Fibrinolytic Agents,
pubmed-meshheading:8017791-Heparin,
pubmed-meshheading:8017791-Hirudins,
pubmed-meshheading:8017791-Humans,
pubmed-meshheading:8017791-Thrombin,
pubmed-meshheading:8017791-Thrombosis
|
pubmed:year |
1994
|
pubmed:articleTitle |
Specific thrombin inhibitors in vivo.
|
pubmed:affiliation |
Centre for Cardiovascular Science, Mater Hospital, University College, Dublin, Ireland.
|
pubmed:publicationType |
Journal Article,
Review
|